Skip to main content

Edwards Lifesciences Corp Rest of World revenue

  • EW · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$107.15+1.28%Close 13 Nov 2026 · Market value $61.51B

Rest of World revenue at Edwards Lifesciences Corp came to $201.3M for the quarter to 30 Sep 2026, up 20.1% from a year earlier.

As Edwards Lifesciences Corp reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$132.1MDec 2023$135.8MMar 2024$144.3MJun 2024$148.6MSep 2024$143.3MDec 2024$150.2MMar 2025$169.0MJun 2025$167.6MSep 2025$165.5MDec 2025$177.8MMar 2026$201.5MJun 2026$201.3MSep 2026
Edwards Lifesciences Corp Rest of World revenue, every reported period
Period endingRest of World revenueChange on a yearFiled
30 Sep 2026$201.3Mup 20.1%4 Nov 2026
30 Jun 2026$201.5Mup 19.2%4 Aug 2026
31 Mar 2026$177.8Mup 18.4%6 May 2026
31 Dec 2025$165.5Mup 15.5%25 Feb 2026
30 Sep 2025$167.6Mup 12.8%5 Nov 2025
30 Jun 2025$169.0Mup 17.1%6 Aug 2025
31 Mar 2025$150.2Mup 10.6%6 May 2025
31 Dec 2024$143.3Mup 8.5%28 Feb 2025
30 Sep 2024$148.6Mup 9.2%6 Nov 2024
30 Jun 2024$144.3Mup 3.7%31 Jul 2024
31 Mar 2024$135.8Mdown 18.0%29 Apr 2024
31 Dec 2023$132.1Mdown 18.3%12 Feb 2024
30 Sep 2023$136.1Mdown 15.4%27 Oct 2023
30 Jun 2023$139.2Mdown 4.6%28 Jul 2023
31 Mar 2023$165.6Mup 16.4%28 Apr 2023
31 Dec 2022$161.6Mup 15.8%13 Feb 2023
30 Sep 2022$160.9Mup 18.2%28 Oct 2022
30 Jun 2022$145.9Mup 9.7%29 Jul 2022
31 Mar 2022$142.3Mup 14.3%28 Apr 2022
31 Dec 2021$139.6Mup 9.0%14 Feb 2022
30 Sep 2021$136.1Mup 18.1%29 Oct 2021
30 Jun 2021$133.0Mup 28.1%30 Jul 2021
31 Mar 2021$124.5Mup 19.3%28 Apr 2021
31 Dec 2020$128.1Mup 9.7%12 Feb 2021
30 Sep 2020$115.2Mup 2.9%26 Oct 2020
30 Jun 2020$103.8Mdown 3.6%27 Jul 2020
31 Mar 2020$104.4Mup 7.9%28 Apr 2020
31 Dec 2019$116.8Mup 10.4%14 Feb 2020
30 Sep 2019$112.0Mup 15.7%25 Oct 2019
30 Jun 2019$107.7Mup 5.9%26 Jul 2019
31 Mar 2019$96.8Mup 5.6%26 Apr 2019
31 Dec 2018$105.8M—15 Feb 2019
30 Sep 2018$96.8Mup 11.1%26 Oct 2018
30 Jun 2018$101.7Mup 9.9%27 Jul 2018
31 Mar 2018$91.7M—27 Apr 2018
30 Sep 2017$87.1M—27 Oct 2017
30 Jun 2017$92.5M—28 Jul 2017
30 Jun 2013$63.1Mup 10.7%6 Aug 2013
31 Mar 2013$54.5Mup 3.4%6 May 2013
31 Dec 2012$64.3Mup 21.6%28 Feb 2013

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Edwards Lifesciences Corp: Transcatheter Aortic Valve Replacement revenue · Surgical revenue · Transcatheter Mitral and Tricuspid Therapies revenue · United States revenue · Europe revenue · Japan revenue · financial statements

Every KPI and segment of EW, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.